Rubinex 100mg Solution for Injection
PDF Leaflet Revision Date: 29 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Short term treatment of hyphaema and coagulopathies.
Dosage (summary)
1.0 to 1.5 g every 8 hours for hyphaema; adjust for renal impairment.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; caution in breastfeeding.
Key Drug Interactions
- Anticoagulants
- Oestrogens
- Thrombolytics
Contraindications
- Hypersensitivity
- Massive upper urinary tract haemorrhage
- Thrombotic tendency
Common side effects
- Convulsions
- Visual disturbances
- Diarrhoea
- Nausea
Counselling Points
- Report any visual disturbances
- Use effective contraception during treatment
- Avoid driving if dizzy
Serious warnings
- Slow IV administration only
- Risk of convulsions
- Potential for thrombus formation
Important Disclaimer
The Rubinex 100mg Solution for Injection professional information leaflet below is the property of Ruby Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
